rhBMP-2/CPM

recombinant human bone morphogenetic protein-2 with calcium phosphate matrix · Wyeth

Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for rhBMP-2/CPM, covering 2007-12-05 to 2020-03-20. Get the full timeline:

Most recent: Clinical Trial Update: Study Evaluating Changes In Bone Mineral Density (BMD), And Safety Of Rhbmp-2/CPM In Subjects With Decreased BMD [Phase 2]

See pricing